| Occurrence of death | OR [IC95%] | p-value | |
Yes | No | |||
Age |
|
|
| 0.052 |
8 - 40 | 18 (29.51) | 43 (70.49) | 1.34 [0.76 - 2.38] |
|
41 - 60 | 35 (23.33) | 115 (76.67) | 1 |
|
>60 | 53 (38.41) | 85 (61.59) | 1.68 [1.09 - 2.58] |
|
Sex |
|
|
| 0.381 |
Male | 48 (28.74) | 119 (71.26) | 1.18 [0.80 - 1.73] |
|
Female | 58 (31.87) | 124 (68.13) | 1 |
|
Charlson’s score |
|
|
| <0.001 |
0 | 1 (6.25) | 15 (93.75) | 1 |
|
1 - 2 | 34 (19.54) | 140 (80.46) | 3.48 [0.47 - 25.45] |
|
≥3 | 71 (44.65) | 88 (55.35) | 9.41 [1.30 - 67.79] |
|
Functional capacity/New York Heart Association classification | 0.032 | |||
Class 1/2 | 4 (12.50) | 28 (97.50) | 1 |
|
Class 3/4 | 102 (32.18) | 215 (67.82) | 2.98 [1.10 - 8.11] |
|
Blood pressure |
|
|
| 0.029 |
<90 mmHg | 12 (52.17) | 11 (47.83) | 1.80 [0.96 - 3.34] |
|
90 - 119 mmHg | 61 (31.44) | 133 (68.56) | 1 |
|
≥120 mmHg | 33 (25.00) | 99 (75.00) | 0.71 [0.46 - 1.09] |
|
Hypokalemia |
|
|
| 0.778 |
Yes | 32 (32.65) | 66 (67.35) | 1.06 [0.70 - 1.60] |
|
No | 74 (29.72) | 175 (70.28) | 1 |
|
Hepatic dysfunction |
|
|
| <0.001 |
Yes | 49 (45.79) | 58 (54.21) | 2.11 [1.44 - 3.10] |
|
No | 57 (24.26) | 178 (75.74) | 1 |
|
Coronary heart disease |
|
|
| 0.611 |
Yes | 65 (31.71) | 140 (68.29) | 1.10 [0.74 - 1.63] |
|
No | 41 (28.47) | 103 (71.53) | 1 |
|
Therapeutic observance |
|
|
| 0.670 |
Good | 27 (26.21) | 76 (73.79) | 1 |
|
Bad | 66 (28.33) | 167 (71.67) | 1.10 [0.70 - 1.72] |
|